Trial Designs: Non-inferiority vs. Superiority vs. Equivalence BlogKnowledge Base Trial Designs: Non-inferiority vs. Superiority vs. Equivalence Understand superiority, non-inferiority, and equivalence trials, how their hypotheses differ, and how trial design impacts…CertaraFebruary 3, 2026
Phoenix Roadshow 2026 – Florence Live Events Phoenix Roadshow 2026 – Florence CertaraFebruary 2, 2026
Population Pharmacokinetics of Clesrovimabin Preterm and Full-Term Infants Publication Population Pharmacokinetics of Clesrovimabin Preterm and Full-Term Infants This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…CertaraFebruary 2, 2026
AI in Alzheimer’s drug development: Where do disease-modifying interventions go from here? Blog AI in Alzheimer’s drug development: Where do disease-modifying interventions go from here? Explore how AI-enabled QSP and model-informed drug development are reshaping Alzheimer’s disease-modifying therapies, from amyloid…CertaraFebruary 2, 2026
Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data Guide Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data SEND data visualization: best practices for visualizing nonclinical study data to reveal trends, spot outliers,…CertaraFebruary 2, 2026
Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach Press Coverage Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach Explore how a collaborative “sandbox” approach—combining flexible regulation, data modeling, and stakeholder engagement—can transform rare…CertaraJanuary 30, 2026
Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®) On-Demand Webinar Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®) Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…CertaraJanuary 30, 2026
Leveraging the full potential of PBPK models to accelerate drug development Webinar Leveraging the full potential of PBPK models to accelerate drug development CertaraJanuary 30, 2026
P21 Enterprise Expands Regulatory Validation Capabilities with Support for the Tobacco Implementation Guide v1.0 Blog P21 Enterprise Expands Regulatory Validation Capabilities with Support for the Tobacco Implementation Guide v1.0 Pinnacle 21 supports TIG v1.0, the CDISC Tobacco Implementation Guide for FDA CTP, enabling automated…CertaraJanuary 30, 2026